ArticleInfection2024
In-label, off-label prescription, efficacy and tolerability of dalbavancin: report from a National Registry.
Silvano Esposito et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it